Listing 1 - 3 of 3 |
Sort by
|
Choose an application
This review is part of a study for the Dutch Health Care Insurance Council [College voor zorgverzekeringen (CVZ)], which has called for a study to develop a generic method of examining combinations of medications.
Arthritis, Rheumatoid -- drug therapy. --- Chemotherapy, Combination. --- Drug Therapy, Combination. --- Rheumatoid arthritis -- Treatment. --- Arthritis, Rheumatoid --- Outcome and Process Assessment (Health Care) --- Drug Therapy, Combination --- Rheumatic Diseases --- Quality of Health Care --- Drug Therapy --- Arthritis --- Health Care Evaluation Mechanisms --- Autoimmune Diseases --- Health Services Administration --- Connective Tissue Diseases --- Immune System Diseases --- Musculoskeletal Diseases --- Joint Diseases --- Therapeutics --- Diagnostic Techniques and Procedures. --- Health Care Quality, Access, and Evaluation --- Diseases --- Skin and Connective Tissue Diseases --- Health Care
Choose an application
This study aims to identify which medications deserve priority for clinical research in the short term. The authors found that a lot of knowledge is already available and needs dissemination rather than further research. However, clinical research on the safety, effectiveness and long term effects of many medications have not been studied yet in children.
Children. --- Pediatric pharmacology. --- Pediatric pharmacology --- Children --- Pharmaceutical Preparations --- Pharmacokinetics --- Psychotropic Drugs --- Drug Therapy --- Child --- Pharmacological Phenomena --- Kinetics --- Therapeutics --- Central Nervous System Agents --- Age Groups --- Metabolic Phenomena --- Diagnostic Techniques and Procedures. --- Therapeutic Uses --- Physiological Phenomena --- Persons --- Biochemical Phenomena --- Chemical Phenomena --- Pharmacologic Actions --- Names. --- Chemical Actions and Uses --- Diseases --- Chemotherapy
Choose an application
This study aims to identify the barriers to effective prescribing for children, with an emphasis upon the absence of good clinical research within those barriers. A group of experts in the field discussed solution directions, in which governmental incentives are deemed critical.
Children. --- Drugs. --- Children --- Pediatric pharmacology --- Therapeutics --- Age Groups --- Kinetics --- Metabolic Phenomena --- Chemical Actions and Uses. --- Pharmacological Phenomena --- Persons --- Physiological Phenomena --- Biochemical Phenomena --- Names --- Chemical Phenomena --- Pharmaceutical Preparations --- Drug Therapy --- Pharmacokinetics --- Child --- Diseases --- Chemotherapy
Listing 1 - 3 of 3 |
Sort by
|